×
Harbor in the Storm: EXL’s AI-powered Code Harbor reduces modernization’s manual efforts by 80%
Written by
Published on
Join our daily newsletter for breaking news, product launches and deals, research breakdowns, and other industry-leading AI coverage
Join Now

Generative and agentic AI are rapidly becoming central drivers of enterprise transformation, enabling businesses to leverage deep data expertise for solving complex challenges. At a recent EXL virtual event, industry leaders shared how AI-powered tools like Code Harbor are dramatically accelerating legacy system modernization by reducing manual effort up to 80% while improving accuracy through business-context-aware migrations rather than simple line-by-line conversions.

The big picture: EXL is demonstrating how specialized AI tools can transform traditional business processes by automating complex workflows and dramatically reducing manual effort across industries.

  • Code Harbor, EXL’s genAI-powered code migration tool, represents a shift from viewing AI as merely a supplementary technology to positioning it as a core driver of business transformation.
  • The solution leverages task-specific AI agents to handle assessment, transformation, optimization, testing and validation of legacy code systems automatically.

Key capabilities: Code Harbor works by analyzing and understanding the business context of code rather than performing traditional line-by-line migrations.

  • Built on EXL’s AI orchestration platform EXLerate.AI and Amazon Web Services, the tool eliminates redundant code and optimizes performance while reducing manual effort by 60-80%.
  • Its modular architecture distributes tasks across multiple AI agents in parallel, significantly increasing both the speed and scalability of migrations.

Why this matters: Legacy system modernization has traditionally been a high-risk, resource-intensive process that creates significant business disruption.

  • By automating and contextualizing the modernization process, Code Harbor helps enterprises reduce both the cost and business risk associated with updating critical legacy technologies.
  • This approach enables companies to modernize their technology stack more rapidly and with greater confidence, accelerating their overall digital transformation efforts.

What they’re saying: “AI is no longer just a tool,” said Vishal Chhibbar, chief growth officer at EXL. “It’s a driver of transformation.”

  • Sujit Singh, partner solutions architect at AWS, noted that “Code Harbor provides a comprehensive solution for customers for code diagnosis, code conversion, testing and code optimization.”
  • According to Swati Malhotra, AI solutions leader at EXL, the solution is “designed to accelerate platform modernization, streamline workflow assessment and enable data discovery, helping organizations drive efficiency, scalability and compliance.”

Beyond code migration: The virtual event also highlighted EXL’s broader AI strategy with additional specialized solutions for targeted business applications.

  • EXL’s Insurance LLM provides purpose-built capabilities for streamlining insurance claims adjudication and underwriting processes.
  • EXLerate.AI combines AI agents with domain-specific large language models to manage and automate complex business workflows across cloud and hybrid environments.
AI in action: Stories of how enterprises are transforming and modernizing

Recent News

Scaling generative AI 4 ways from experiments to production

Organizations face significant hurdles when moving generative AI initiatives from experimentation to production-ready systems, with most falling short of deployment goals despite executive interest.

Google expands Gemini AI with 2 new plans, leak reveals

Google prepares to introduce multiple subscription tiers for Gemini, addressing the gap between its free and premium AI offerings.

AI discovers potential Alzheimer’s cause and treatment

AI identifies PHGDH gene as a direct cause of Alzheimer's disease beyond its role as a biomarker, offering a new understanding of spontaneous cases and potential treatment pathways.